Comparative in vitro activity of norfloxacin against urinary tract pathogens

[1]  S.‐K. Chung,et al.  Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents , 2005, Infection.

[2]  H. Neu,et al.  In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim , 1982, Antimicrobial Agents and Chemotherapy.

[3]  G. Harding,et al.  Therapy for acute cystitis in adult women. Randomized comparison of single-dose sulfisoxazole vs trimethoprim-sulfamethoxazole. , 1982, JAMA.

[4]  I. Phillips,et al.  In vitro antibacterial activity of norfloxacin (MK-0366) , 1982, Antimicrobial Agents and Chemotherapy.

[5]  J. Ryan,et al.  In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa , 1982, Antimicrobial Agents and Chemotherapy.

[6]  L. Nicolle,et al.  Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women. , 1982, Reviews of Infectious Diseases.

[7]  C. Liu,et al.  Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients. , 1982, Reviews of infectious diseases.

[8]  R. Rubin,et al.  Single-Dose Amoxicillin Therapy for Urinary Tract Infection-Reply , 1981 .

[9]  H. Rubinoff.  Single-dose amoxicillin therapy for urinary tract infection. , 1981, JAMA.

[10]  J. Preiksaitis,et al.  A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae. , 1981, The Journal of infectious diseases.

[11]  R. Rubin,et al.  Single-Dose Amoxicillin Therapy for Urinary Tract Infection: Multicenter Trial Using Antibody-Coated Bacteria Localization Technique , 1980 .

[12]  K. Holmes,et al.  Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. , 1980, Annals of internal medicine.

[13]  S. Mitsuhashi,et al.  In Vitro Antibacterial Activity of AM-715, a New Nalidixic Acid Analog , 1980, Antimicrobial Agents and Chemotherapy.

[14]  S. Mitsuhashi,et al.  In Vitro and in Vivo Antibacterial Activity of AM-715 — a New Analog of Nalidixic Acid , 1980 .

[15]  G. Harding,et al.  Prophylaxis of recurrent urinary tract infection in female patients. Efficacy of low-dose, thrice-weekly therapy with trimethoprim-sulfamethoxazole. , 1979, JAMA.

[16]  C. Wong,et al.  Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole. , 1975, Canadian Medical Association journal.

[17]  G. Harding,et al.  A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. , 1974, The New England journal of medicine.

[18]  U. Koch,et al.  Efficacy of trimethoprim, sulfamethoxazole and the combination of both in acute urinary tract infection. Clinical and pharmacokinetical studies. , 1973, Chemotherapy.

[19]  W. Brumfitt,et al.  Double-blind Trial to Compare Ampicillin, Cephalexin, Co-trimoxazole, and Trimethoprim in Treatment of Urinary Infection , 1972, British medical journal.

[20]  P. Gower,et al.  Prevention of urinary-tract infection with low-dose nitrofurantoin. , 1971, Lancet.

[21]  E. Steers,et al.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. , 1959, Antibiotics & chemotherapy.